PRIMAEGISresearch
← Screener
SETL

SETL

Medical Specialties/ 1 document · covered since Jul 2026
Latest view
as of 25 Jul 2026 · not a recommendation

Evidence timeline

What management said

from NSE earnings-call filings · extracted, not interpreted
Call 20-May-2026 · transcript PDF

Outlook, as stated

Nageswara Kandula: That capex investment maybe greenfield investment, maybe -- first year maybe -- next year maybe we are going to invest INR70 crores to INR100 crores, we feel we're going to invest on that project.

Ram Arvind: Since already our revenues is close to 80% catering to the pharma sector, right, and even the glass-lined shell and tube exchangers will again -- I assume that will be going towards the pharma sector.

Firstly, we are -- this year we are going to invest INR65 crores, next year we are going to another INR65 crores we are going to invest on that facility.

3.95 concrete references per 100 words spoken — counts, currency, units and named periods, not adjectives

Chart exhibits

as drawn · not updated since

No forward scenario

the call carried no figure that bridges to earnings growth.

Price chart

260 sessions to 31 Jul 2026 · daily close · our own broker data
100 200 300 Jul Sep Nov 2026 Mar May Jul vol 275.1
14 Jul 2025 → 31 Jul 2026 low ₹105.65 · high ₹296.55 · last ₹275.1 · 48.5% over the window close 50-DMA 200-DMA